HDAC inhibitors: much to learn about effective therapy.
Marks
Paul A
PA
Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D056572:Histone Deacetylase Inhibitors